You'll see patients getting Arimidex for EARLY breast cancer
October 2002
You'll see patients getting Arimidex for EARLY breast cancer.
Arimidex (anastrozole) just got approved in the U.S. for early breast cancer. Health Canada is considering it.
Tamoxifen is currently the standard for women with estrogen receptor-positive breast cancer.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive